> News > Ludwig Cancer Research, EPFL, CHUV and Roche collaboration leads to major breakthrough in cancer research
23.01
2023

Ludwig Cancer Research, EPFL, CHUV and Roche collaboration leads to major breakthrough in cancer research

Breakthrough in cancer research: a team of scientists has found a way to break down, the resistance of neuroendocrine pancreatic cancer to immunotherapy, resulting in increased survival rates in mice. Combining PD1-IL2v with anti-PD-L1 proved to be more effective than using just one of the molecules. The study published in Immunity results from a collaboration between scientists at EPFL, Ludwig Institute for Cancer Research, CHUV and Roche.

Read more on EPFL.ch

Company related to the news